A Randomized, Double-blind, Placebo-controlled, 3 Dose Level, Parallel Group Study of the Efficacy and Safety of Plecanatide in Adolescents 12 to < 18 Years of Age With Chronic Idiopathic Constipation (CIC)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Jan 2019
At a glance
- Drugs Plecanatide (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Synergy Pharmaceuticals Inc
- 10 Jan 2019 Planned End Date changed from 1 Sep 2018 to 1 Apr 2019.
- 18 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 21 Apr 2017 New trial record